(Note: this is my 200th post on this blog.. not bad for an arm-chair activist!)
Great sound bite Mr Witty Sir… Or is it just Sir Witty?.. I think I’ll just call you Andrew.. or how about Andy?.. I’ll leave out the Sir thanks…
Personally, I don’t buy into the perpetuation of an unfair class system through titles, all a little bit too Colonial and ‘old dead empire ideology’ for me to be honest.. Just not into it.. but anyway..
I find it utterly amazing how GSK attempts to clean up its image with soundbites and PR stunts, while at the same time they leave victims of Seroxat (in their home country of England) with no help, support or aid in dealing with some of the most frightening drug side effects ever unleashed from a (legal) drug…
” Good Things Happen When You Do Good Things” ..
Well, How about you address the problem of Seroxat..
It’s not going to go away Andrew..
Not anytime soon..
Certainly not in my lifetime, or the lifetime of others whom have made it their mission to bring awarness to the Seroxat scandal until their last breath .. Yes, we are that pissed off!… really we are..
I mean it’s only just and right isn’t it? We as Seroxat victims doing the “good thing” by warning others about this sinister and defective drug .. Do you think that’s the right thing? or are you just flippant about soundbites? ..
You see, this is about Justice, Not some lofty Ideal or PR soundbite, actual real natural justice..
What GSK did with the lies to consumers about Seroxat was a very very bad thing..
Until it is atoned..
We’ll continue on..
http://guest.thirdsector.co.uk/2012/01/27/breaking-the-silos/
Abandoning the defensive posture which enshrouds much discussion of business, Witty, without either notes or a podium, stood up to set out a bold and ambitious vision for the future of business that was “in step with society” and where “good things will happen when you do good things”.
As if to anticipate the audience’s scepticism, Witty emphasised that the substance of business must change not just the rhetoric. For GSK, that meant action on animal testing, AIDS vaccines and aggressive efforts to reduce the price of drugs and pool patents. And for GSK’s 110,000 employees it means that the support and engagement of employees becomes part of core business practice and a responsible business strategy – from match-funding schemes and volunteering opportunities to rising young executives spending time in Nairobi’s slums.
